Apolipoprotein(a) size polymorphism in young adults with ischemic stroke.

[1]  M. Schroll,et al.  Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control study. , 1997, Atherosclerosis.

[2]  S. Fortmann,et al.  A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[3]  M. Taskinen,et al.  Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[4]  P. Wilson,et al.  Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. , 1996, JAMA.

[5]  W. Ryu,et al.  Effect of Hormone Replacement Therapy on Lipoprotein(a) and Lipid Levels in Postmenopausal Women: Influence of Various Progestogens and Duration of Therapy , 1996 .

[6]  D. Nagaraja,et al.  Case‐control study of serum lipoprotein(a) and apolipoproteins A‐I and B in stroke in the young , 1996, Acta neurologica Scandinavica.

[7]  S. Biro,et al.  High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease. , 1996, American heart journal.

[8]  P. Koudstaal,et al.  Lipoprotein(a) in patients with acute cerebral ischemia. , 1996, Stroke.

[9]  F. Kronenberg,et al.  Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[10]  K. Kario,et al.  'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[11]  M. Margaglione,et al.  109. Comparison of plasma lipoprotein (a) levels between individuals attending a metabolic ward with and without a history of ischemic stroke , 1996 .

[12]  T. Kobayashi,et al.  Lipoprotein(a) is an independent risk factor for multiple cerebral infarctions. , 1996, Atherosclerosis.

[13]  H. Hobbs,et al.  Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. , 1996, Clinical chemistry.

[14]  D. Rader,et al.  Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation. , 1995, The American journal of pathology.

[15]  A. Stead,et al.  Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. , 1995, Stroke.

[16]  H. Hobbs,et al.  Sequence microheterogeneity in apolipoprotein(a) gene repeats and the relationship to plasma Lp(a) levels. , 1995, Human molecular genetics.

[17]  O. Faergeman,et al.  Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction. The EARS Study. European Atherosclerosis Research Study. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[18]  G. Utermann,et al.  The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes. , 1995, Atherosclerosis.

[19]  P. Ridker,et al.  Plasma concentration of lipoprotein(a) and the risk of future stroke. , 1995, JAMA.

[20]  E. Boerwinkle,et al.  Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. , 1995, Human molecular genetics.

[21]  K. Berg,et al.  Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction , 1994, Clinical genetics.

[22]  M. Kamboh,et al.  Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[23]  L. Chambless,et al.  Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: the ARIC Study. Atherosclerosis Risk in Communities. , 1994, Annals of epidemiology.

[24]  M. Farrer,et al.  Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[25]  G. Boysen,et al.  Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study , 1994, BMJ.

[26]  R. Muche,et al.  Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS) , 1994, European journal of clinical investigation.

[27]  M. Sentí,et al.  Influence of Apolipoprotein(a) Genetic Polymorphism on Serum Lipoprotein(a) Concentration in Patients with Ischemic Cerebrovascular Disease , 1994 .

[28]  J. Ordovás,et al.  Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. , 1994, JAMA.

[29]  Y. Shinohara,et al.  Lipoprotein(a) and Ischemic Cerebrovascular Disease in Young Adults , 1994, Stroke.

[30]  E. Boerwinkle,et al.  The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[31]  H. Hobbs,et al.  Molecular definition of the extreme size polymorphism in apolipoprotein(a). , 1993, Human molecular genetics.

[32]  A. Sharrett,et al.  Lipoprotein[a] as a risk factor for preclinical atherosclerosis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[33]  S. Marcovina,et al.  Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. , 1993, Biochemical and biophysical research communications.

[34]  F. Kronenberg,et al.  Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). , 1993, The Journal of clinical investigation.

[35]  A. Jovicić,et al.  Lipoprotein(a) in patients with carotid atherosclerosis and ischemic cerebrovascular disorders. , 1993, Atherosclerosis.

[36]  B. Norrving,et al.  Plasma lipids and lipoproteins in subtypes of stroke , 1992, Acta neurologica Scandinavica.

[37]  M. Sentí,et al.  Lipoprotein and Apolipoprotein Profile in Men With Ischemic Stroke: Role of Lipoprotein (a), Triglyceride‐Rich Lipoproteins, and Apolipoprotein E Polymorphism , 1992, Stroke.

[38]  E. Boerwinkle,et al.  Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[39]  E. Boerwinkle,et al.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.

[40]  R. Ferrell,et al.  Expressed hypervariable polymorphism of apolipoprotein (a). , 1991, American journal of human genetics.

[41]  J. Huttunen,et al.  Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. , 1991, Atherosclerosis.

[42]  D. Rouy,et al.  Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[43]  J. Woo,et al.  Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese. , 1991, Stroke.

[44]  L. Wilhelmsen,et al.  Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.

[45]  L. Romics,et al.  Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. , 1989, Clinical chemistry.

[46]  M. Seishima,et al.  Transient changes of serum lipoprotein(a) as an acute phase protein. , 1989, Atherosclerosis.

[47]  A. Albertini,et al.  Improved radioimmunoassay of atrial natriuretic peptide in plasma. , 1989, Clinical chemistry.

[48]  A. Scanu,et al.  A potential basis for the thrombotic risks associated with lipoprotein(a) , 1989, Nature.

[49]  D. Jacobs,et al.  Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. , 1989, The New England journal of medicine.

[50]  G. Beck,et al.  Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. , 1988, Circulation.

[51]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[52]  G. Jürgens,et al.  Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. , 1987, Neurology.

[53]  V. Armstrong,et al.  The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. , 1986, Atherosclerosis.

[54]  A. Gotto,et al.  CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .

[55]  M. Kameyama,et al.  Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. , 1986, Atherosclerosis.

[56]  M. Feinleib,et al.  Serum Triglyceride and Risk of Coronary Heart Disease, Stroke, and Total Mortality in Japanese‐American Men , 1983, Arteriosclerosis.

[57]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[58]  M. Margaglione,et al.  Plasma lipoprotein(a) levels in subjects attending a metabolic ward. Discrimination between individuals with and without a history of ischemic stroke. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[59]  S. Duffy,et al.  Lipids Are Risk Factors for Ischaemic Stroke: Overview and Review , 1992 .

[60]  G. Dahlén.  Chapter 11 – Incidence of Lp(a) Lipoprotein among Populations , 1990 .